219 related articles for article (PubMed ID: 29950348)
1. Mutational Analysis Identifies Therapeutic Biomarkers in Inflammatory Bowel Disease-Associated Colorectal Cancers.
Din S; Wong K; Mueller MF; Oniscu A; Hewinson J; Black CJ; Miller ML; Jiménez-Sánchez A; Rabbie R; Rashid M; Satsangi J; Adams DJ; Arends MJ
Clin Cancer Res; 2018 Oct; 24(20):5133-5142. PubMed ID: 29950348
[No Abstract] [Full Text] [Related]
2. Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.
Robles AI; Traverso G; Zhang M; Roberts NJ; Khan MA; Joseph C; Lauwers GY; Selaru FM; Popoli M; Pittman ME; Ke X; Hruban RH; Meltzer SJ; Kinzler KW; Vogelstein B; Harris CC; Papadopoulos N
Gastroenterology; 2016 Apr; 150(4):931-43. PubMed ID: 26764183
[TBL] [Abstract][Full Text] [Related]
3. Morphological, immunophenotypical and molecular features of hypermutation in colorectal carcinomas with mutations in DNA polymerase ε (POLE).
Forgó E; Gomez AJ; Steiner D; Zehnder J; Longacre TA
Histopathology; 2020 Feb; 76(3):366-374. PubMed ID: 31479159
[TBL] [Abstract][Full Text] [Related]
4. Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.
Svrcek M; El-Bchiri J; Chalastanis A; Capel E; Dumont S; Buhard O; Oliveira C; Seruca R; Bossard C; Mosnier JF; Berger F; Leteurtre E; Lavergne-Slove A; Chenard MP; Hamelin R; Cosnes J; Beaugerie L; Tiret E; Duval A; Fléjou JF
J Clin Oncol; 2007 Sep; 25(27):4231-8. PubMed ID: 17878476
[TBL] [Abstract][Full Text] [Related]
5. MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes.
Donehower LA; Creighton CJ; Schultz N; Shinbrot E; Chang K; Gunaratne PH; Muzny D; Sander C; Hamilton SR; Gibbs RA; Wheeler D
J Pathol; 2013 Jan; 229(1):99-110. PubMed ID: 22899370
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of microRNAs-155 and 21 targeting mismatch repair proteins in inflammatory bowel diseases.
Svrcek M; El-Murr N; Wanherdrick K; Dumont S; Beaugerie L; Cosnes J; Colombel JF; Tiret E; Fléjou JF; Lesuffleur T; Duval A
Carcinogenesis; 2013 Apr; 34(4):828-34. PubMed ID: 23288924
[TBL] [Abstract][Full Text] [Related]
7. Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancers.
Olaru AV; Cheng Y; Agarwal R; Yang J; David S; Abraham JM; Yu W; Kwon JH; Lazarev M; Brant SR; Marohn MR; Hutcheon DF; Harpaz N; Meltzer SJ; Mori Y
Inflamm Bowel Dis; 2012 Apr; 18(4):641-8. PubMed ID: 21830278
[TBL] [Abstract][Full Text] [Related]
8. Homologous Recombination Repair Truncations Predict Hypermutation in Microsatellite Stable Colorectal and Endometrial Tumors.
Lee M; Eng G; Barbari SR; Deshpande V; Shcherbakova PV; Gala MK
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00149. PubMed ID: 32352724
[TBL] [Abstract][Full Text] [Related]
9. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer.
Rajamäki K; Taira A; Katainen R; Välimäki N; Kuosmanen A; Plaketti RM; Seppälä TT; Ahtiainen M; Wirta EV; Vartiainen E; Sulo P; Ravantti J; Lehtipuro S; Granberg KJ; Nykter M; Tanskanen T; Ristimäki A; Koskensalo S; Renkonen-Sinisalo L; Lepistö A; Böhm J; Taipale J; Mecklin JP; Aavikko M; Palin K; Aaltonen LA
Gastroenterology; 2021 Aug; 161(2):592-607. PubMed ID: 33930428
[TBL] [Abstract][Full Text] [Related]
10. Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers.
Alpert L; Yassan L; Poon R; Kadri S; Niu N; Patil SA; Mujacic I; Montes D; Galbo F; Wurst MN; Zhen CJ; Cohen RD; Rubin DT; Pekow JR; Weber CR; Xiao SY; Hart J; Segal J; Setia N
Hum Pathol; 2019 Jul; 89():44-50. PubMed ID: 31054900
[TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas.
Wang J; Li R; He Y; Yi Y; Wu H; Liang Z
Mod Pathol; 2020 Dec; 33(12):2591-2601. PubMed ID: 32620917
[TBL] [Abstract][Full Text] [Related]
12. Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients.
Johansen AFB; Kassentoft CG; Knudsen M; Laursen MB; Madsen AH; Iversen LH; Sunesen KG; Rasmussen MH; Andersen CL
BMC Cancer; 2019 Oct; 19(1):971. PubMed ID: 31638937
[TBL] [Abstract][Full Text] [Related]
13. Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
de Krijger M; Carvalho B; Rausch C; Bolijn AS; Delis-van Diemen PM; Tijssen M; van Engeland M; Mostafavi N; Bogie RMM; Dekker E; Masclee AAM; Verheij J; Meijer GA; Ponsioen CY
Inflamm Bowel Dis; 2022 Sep; 28(9):1309-1320. PubMed ID: 35554535
[TBL] [Abstract][Full Text] [Related]
14. Mutational profiling of colorectal cancers with microsatellite instability.
Lin EI; Tseng LH; Gocke CD; Reil S; Le DT; Azad NS; Eshleman JR
Oncotarget; 2015 Dec; 6(39):42334-44. PubMed ID: 26517354
[TBL] [Abstract][Full Text] [Related]
15. Identification of Positively and Negatively Selected Driver Gene Mutations Associated With Colorectal Cancer With Microsatellite Instability.
Jonchere V; Marisa L; Greene M; Virouleau A; Buhard O; Bertrand R; Svrcek M; Cervera P; Goloudina A; Guillerm E; Coulet F; Landman S; Ratovomanana T; Job S; Ayadi M; Elarouci N; Armenoult L; Merabtene F; Dumont S; Parc Y; Lefèvre JH; André T; Fléjou JF; Guilloux A; Collura A; de Reyniès A; Duval A
Cell Mol Gastroenterol Hepatol; 2018; 6(3):277-300. PubMed ID: 30116770
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.
Hirsch D; Wangsa D; Zhu YJ; Hu Y; Edelman DC; Meltzer PS; Heselmeyer-Haddad K; Ott C; Kienle P; Galata C; Horisberger K; Ried T; Gaiser T
Clin Cancer Res; 2018 Oct; 24(20):4997-5011. PubMed ID: 29967250
[No Abstract] [Full Text] [Related]
17. Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancer.
Jin HY; Liu X; Li VK; Ding Y; Yang B; Geng J; Lai R; Ding S; Ni M; Zhao R
BMC Cancer; 2008 Feb; 8():44. PubMed ID: 18257912
[TBL] [Abstract][Full Text] [Related]
18. Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer.
Carethers JM; Jung BH
Gastroenterology; 2015 Oct; 149(5):1177-1190.e3. PubMed ID: 26216840
[TBL] [Abstract][Full Text] [Related]
19. An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy.
Sibilio P; Belardinilli F; Licursi V; Paci P; Giannini G
Biol Direct; 2022 May; 17(1):10. PubMed ID: 35534873
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.
Georgeson P; Pope BJ; Rosty C; Clendenning M; Mahmood K; Joo JE; Walker R; Hutchinson RA; Preston S; Como J; Joseland S; Win AK; Macrae FA; Hopper JL; Mouradov D; Gibbs P; Sieber OM; O'Sullivan DE; Brenner DR; Gallinger S; Jenkins MA; Winship IM; Buchanan DD
Gut; 2021 Nov; 70(11):2138-2149. PubMed ID: 33414168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]